Previous studies have demonstrated the activation of NLRP3/caspase-1/IL-1β in podocytes derived from patients with DN, db/db mice, and streptozotocin (STZ)-induced mice/rats [27, 32]. This evidence concerns the gene NLRP3 and liver dysplastic nodule.